If you aren't familiar with Avanex below is some useful information. They changed the primary endpoint from the CGI-I to the RSBQ during the trial and ultimately the development hasn't gone further (to date). Interestingly they also changed to include the Anxiety, Depression, and Mood Scale (ADAMS) scale as a secondary endpoint which wasn't there originally.
Btw: Not suggesting that NTI is moving the goal posts like Anavex did. It is simply to show how particular the FDA is with these things.
Source: Blarcamesine Shows Promise as Potential Rett Syndrome Treatment, New Data Indicate (neurologylive.com)
- Forums
- ASX - By Stock
- Ann: Further Significant Improvement in Rett Syndrome Patients
If you aren't familiar with Avanex below is some useful...
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.1¢ |
Change
0.001(1.43%) |
Mkt cap ! $72.24M |
Open | High | Low | Value | Volume |
7.1¢ | 7.2¢ | 7.0¢ | $53.03K | 748.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 269144 | 7.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.1¢ | 105527 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14280 | 0.070 |
1 | 36231 | 0.069 |
6 | 248000 | 0.068 |
3 | 265000 | 0.067 |
3 | 262000 | 0.066 |
Price($) | Vol. | No. |
---|---|---|
0.071 | 105527 | 2 |
0.072 | 77591 | 1 |
0.074 | 40000 | 1 |
0.075 | 738582 | 2 |
0.077 | 150000 | 2 |
Last trade - 15.44pm 13/09/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online